Placeholder image

Yakini S. Brandy

Visiting Assistant Professor of Chemistry

Phone: 404.471.6388
Office Location: BSC301W

Academic Degrees

  • B.S. Chemistry, University of the Virgin Islands
  • Ph.D. Organic Chemistry, Howard University

Professional Activities

  • Ogindo, C.O.; Khraiwesh, M.H.; George, M. Jr.; Brandy, Y.; Brandy, N.; Gugssa, A.; Ashraf, M.; Abbas, M.A.; Southerland, W.M.; Lee, C.M.; Barake, O. and Fang, Yayin. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives. Bioorganic & Medicinal Chemistry 2016, 24, 3849-3855. http://dx.doi.org/10.1016/j.bmc.2016.06.031.
  • Bakare, Oladapo; Lee, Clarence M.; Brandy, Yakini; Khraiwesh, Mozna Husein.”Method for inhibiting Trypanosoma cruzi ”. U.S. Patent 9422231 filed July 27, 2012 and issued August 23, 2016.
  • Bakare, Oladapo; Lee, Clarence M.; Brandy, Yakini; Manka, Cheu. “Methods for treating Leishmaniasis”. U.S. Publication No. 20140336187 filed November 16, 2012 and published November 13, 2014.
  • Bakare, O.; Thompson, C.; Brandy, Y.; and Butcher R. J. 2-Chloro-n-(2-chloro-benzo-yl)-N-(2-ethyl-4-oxo-3,4-di-hydro-quinazolin-3-yl)benzamide. Acta Cryst Sect. E. Struct Rep Online. 2014 70(4) o503-4. doi: 10.1107/S1600536814006035. 
  • Brandy, Y.; Brandy, N.; Akinboye, E.; Lewis, M.; Mouamba C.; Mack, S.; Butcher R.J.; Anderson, A.J.; and Bakare, O. Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo-or 3–Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives. Molecules 2013, 18, 1973-1984. DOI 10.3390/molecules18021973.
  • Brandy, Y.; Butcher, R.J.; and Bakare O. N-(1,4-dioxonaphthalen-2-yl)-benzamide. Acta Cryst. 2012, E68(9), o2775-o2776. DOI: 10.1107/S1600536812034150.
  • Brandy, Y.; Butcher, R.J.; and Bakare O. N-Benzoyl-N-(1,4-dioxonaphthalen-2-yl)-benzamide. Acta Cryst. 2012, E68, o2379. DOI: 10.1107/S1600536812030231.
  • Khraiwesh, H. M.; Lee, C.M.; Brandy, Y.; Akinboye E. S.; Berhe, S.; Gittens, G.; Abbas, M M.; Ampy, F. R.; Ashraf, M.; Bakare, O. Antitrypanosomal activities and cytotoxicity of some novel imido- substituted 1,4-naphthoquinone derivatives. Arch. Pharm. Res. 2011, 35(1), 27-33. DOI 10.1007/s12272-012-0103-1.
  • Brandy, Y.; Ononiwu, I.; Adedeji, D.; Williams, V.; Mouamaba, C.; Kanaan, Y.; Copeland, R. L.; Wright, D. A.; Butcher, R.J.; Denmeade, S.R. and Bakare, O. Synthesis and Cytotoxic Activities of Some 2-Arylnaphtho[2,3-d]oxazole-4,9-dione Derivatives on Androgen-dependent (LNCap) and Androgen-independent (PC3) Human Prostate Cancer Cell Lines. Investigational New Drugs.2011. DOI 10.1007/s10637-011-9635-3.
  • Akinboye, E. S.; Butcher, R. J.; Wright, D. A.; Brandy, Y.; and Bakare, O. N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphthyl0-4-fluoro-N-(4-fluorobenzoyl)benzamide. Acta Cryst. 2009, E65(2), o277.
  • Brandy, Y.; Bucher, R. J.; Adesiyun, T. A.; Berhe, S.; and Bakare, O. 2-Chloro-3-(4-chlorobenzamido)-1,4-naphthoquinone. Acta Cryst. 2009, E65(1), o64.
  • Akinboye, E. S; Butcher, R. J.; Brandy, Y.; Adesiyun, T.; and Bakare, O. N-(3-Bromo-1,4-dioxo-1,4-dihydo-2-naphthyl)-2-chloro-N-(2-chlorobenzoyl)benzamide.Acta, Cryst. 2009, E65(1), o24.
Back to top